Functional renal MRI

Current Medical Imaging Reviews

Volumn 8, Issue 2, 2012, Pages 122-134

  Prasad, Pottumarthi V ^a   Haque, Muhammad ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Arterial spin labeling (ASL); Blood oxygenation level dependent (BOLD); Diffusion; Glomerular filtration rate (GFR); Kidney; Magnetic resonance imaging (MRI); Renal blood flow (RBF)

Indexed keywords

BLOOD; FUNCTION EVALUATION; OXYGENATION;

ARTERIAL SPIN LABELING; BLOOD OXYGENATION LEVEL DEPENDENT; GLOMERULAR FILTRATION RATE; KIDNEY; MAGNETIC RESONANCE IMAGING; RENAL BLOOD FLOW;

MAGNETIC RESONANCE IMAGING;

ACETAZOLAMIDE; CARBON 13; CREATININE; DEOXYHEMOGLOBIN; ECHOVIST; GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOFOSVESET; GADOLINIUM PENTETATE; GADOTERATE MEGLUMINE; GADOTERIDOL; NITRIC OXIDE; SODIUM 23;

ABDOMINAL AORTA; ASCENDING AORTA; BIOAVAILABILITY; BOLD SIGNAL; CONTRAST ENHANCEMENT; CREATININE CLEARANCE; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; ELECTRON SPIN RESONANCE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HEMATOCRIT; HUMAN; HYPERPOLARIZATION; IN VIVO STUDY; KIDNEY; KIDNEY ARTERY; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY MEDULLA; KIDNEY PERFUSION; KIDNEY PLASMA FLOW; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MAGNETIC FIELD; NEPHROGENIC SYSTEMIC FIBROSIS; NEPHRON; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; OXYGEN TENSION; PH; PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; SPIN LABELING; URINARY EXCRETION;

EID: 84861775968     PISSN: 15734056     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/157340512800672171     Document Type: Review

References (140)

1. Waters EA, Wickline SA. Contrast agents for MRI. Basic. Res Cardiol 2008; 103(2): 114-21.
2. Lowe MP. Activated MR contrast agents. Curr Pharm Biotechnol 2004; 5(6): 519-528.
3. Lloyd D. Functional MRI and the study of human consciousness. J Cogn Neurosci 2002; 14(6): 818-31.
4. Stiles J, Moses P, Passarotti A, Dick FK, Buxton R. Exploring developmental change in the neural bases of higher cognitive functions: the promise of functional magnetic resonance imaging. Dev Neuropsychol 2003; 24(2-3): 641-68.
5. Cho ZH, Chung SC, Jones JP, et al. New findings of the correlation between acupoints and corresponding brain cortices using functional MRI. Proc Natl Acad Sci U S A 1998; 95(5): 2670-3.
6. Cho ZH, Oleson TD, Alimi D, Niemtzow RC. Acupuncture: the search for biologic evidence with functional magnetic resonance imaging and positron emission tomography techniques. J Altern Complement Med 2002; 8(4): 399-401.
7. Holden C. Polygraph screening. Panel seeks truth in lie detector debate. Science 2001; 291(5506): 967.
8. Langleben DD, Schroeder L, Maldjian JA, et al. Brain activity during simulated deception: an event-related functional magnetic resonance study. Neuroimage 2002; 15(3): 727-732.
9. Lo YL, Fook-Chong S, Tan EK. Increased cortical excitability in human deception. Neuroreport 2003; 14(7): 1021-4.
10. Prasad PV. Functional MRI of the kidney: tools for translational studies of pathophysiology of renal disease. Am J Physiol Renal Physiol 2006; 290(5): F958-974.
11. Rorschach HE, Lin C, Hazlewood CF. Diffusion of water in biological tissues. Scanning Microsc Suppl 1991; 5(4): S1-9; discussion S9-10.
12. Muller MF, Prasad P, Siewert B, et al. Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 1994; 190(2): 475-8.
13. Muller MF, Prasad PV, Bimmler D, Kaiser A, Edelman RR. Functional imaging of the kidney by means of measurement of the apparent diffusion coefficient. Radiology 1994; 193(3): 711-5.
14. Kim S, Naik M, Sigmund E, Taouli B. Diffusion-weighted MR imaging of the kidneys and the urinary tract. Magn Reson Imaging Clin N Am 2008; 16(4): 585-96, vii-viii.
15. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161(2): 401-7.
16. Le Bihan D, Turner R. Intravoxel incoherent motion imaging using spin echoes. Magn Reson Med 1991; 19(2): 221-7.
17. Namimoto T, Yamashita Y, Mitsuzaki K, et al. Measurement of the apparent diffusion coefficient in diffuse renal disease by diffusionweighted echo-planar MR imaging. J Magn Reson Imaging 1999; 9(6): 832-7.
18. Knox FG, Ritman EL, Romero JC. Intrarenal distribution of blood flow: evolution of a new approach to measurement. Kidney Int 1984; 25(3): 473-9.
19. Laiken ND, Fanestil DD. Physiology of the body fluids. In: West JB, editor. Best and Taylor's physiological basis of medical practice. 12th ed. Baltimore: Williams &Wilkins 1990; 406-18.
20. Knepper MA, Rector FC. Urinary concentration and dilution. In: Brenner BM, Rector FC, editors. The kidney. 4th ed. Philadelphia: WB Saunders 1991; 445-82.
21. Thoeny HC, De Keyzer F, Oyen RH, Peeters RR. Diffusionweighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology 2005; 235(3): 911-7.
22. Fukuda Y, Ohashi I, Hanafusa K, et al. Anisotropic diffusion in kidney: apparent diffusion coefficient measurements for clinical use. J Magn Reson Imaging 2000; 11(2): 156-60.
23. Ries M, Jones RA, Basseau F, Moonen CT, Grenier N. Diffusion tensor MRI of the human kidney. J Magn Reson Imaging 2001; 14(1): 42-9.
24. Engelter ST, Wetzel SG, Bonati LH, Fluri F, Lyrer PA. The clinical significance of diffusion-weighted MR imaging in stroke and TIA patients. Swiss Med Wkly 2008; 138(49-50): 729-40.
25. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11(2): 102-25.
26. Yablonskiy DA, Sukstanskii AL, Woods JC, et al. Quantification of lung microstructure with hyperpolarized 3He diffusion MRI. J Appl Physiol 2009; 107(4): 1258-65.
27. Carbone SF, Gaggioli E, Ricci V, et al. Diffusion-weighted magnetic resonance imaging in the evaluation of renal function: a preliminary study. Radiol Med 2007; 112(8): 1201-10.
28. Sandrasegaran K, Akisik FM, Lin C, et al. Value of diffusionweighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 2009; 193(6): 1556-60.
29. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99(6): 1160-74.
30. Williams DS. Quantitative perfusion imaging using arterial spin labeling. Methods Mol Med 2006; 124: 151-173.
31. Buxton RB, Frank LR, Wong EC, et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998; 40(3): 383-96.
32. Zhang W, Williams DS, Detre JA, Koretsky AP. Measurement of brain perfusion by volume-localized NMR spectroscopy using inversion of arterial water spins: accounting for transit time and cross-relaxation. Magn Reson Med 1992; 25(2): 362-71.
33. Martirosian P, Klose U, Mader I, Schick F. FAIR true-FISP perfusion imaging of the kidneys. Magn Reson Med 2004; 51(2): 353-361.
34. Dworkin LD, Brenner BM. The renal circulation. In: Brenner BM, Rector FC, editors. The kidney. Philadelphia: Saunders.1981.
35. Lorenz CH, Powers TA, Partain CL. Quantitative imaging of renal blood flow and function. Invest Radiol 1992; 27 Suppl 2: S109-114.
36. Ritt M, Janka R, Schneider MP, et al. Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant 2009.
37. Brezis M, Rosen S. Hypoxia of the renal medulla--its implications for disease. N Engl J Med 1995; 332(10): 647-55.
38. Eckardt KU, Bernhardt WM, Weidemann A, et al. Role of hypoxia in the pathogenesis of renal disease. Kidney Int Suppl 2005; (99): S46-51.
39. Norman JT, Fine LG. Intrarenal oxygenation in chronic renal failure. Clin Exp Pharmacol Physiol 2006; 33(10): 989-96.
40. Epstein FH, Agmon Y, Brezis M. Physiology of renal hypoxia. Ann N Y Acad Sci 1994; 718: 72-81; discussion 81-72.
41. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol 1994; 267(6 Pt 2): F1059-62.
42. Liss AG, Liss P. Use of a modified oxygen microelectrode and laser-Doppler flowmetry to monitor changes in oxygen tension and microcirculation in a flap. Plast Reconstr Surg 2000; 105(6): 2072-2078.
43. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003; 46(8): 1153-60.
44. Braun RD, Lanzen JL, Snyder SA, Dewhirst MW. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am J Physiol Heart Circ Physiol 2001; 280(6): H2533-44.
45. Zhong Z, Arteel GE, Connor HD, et al. Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 1998; 275(4 Pt 2): F595-604.
46. Rosenberger C, Goldfarb M, Shina A, et al. Evidence for sustained renal hypoxia and transient hypoxia adaptation in experimental rhabdomyolysis-induced acute kidney injury. Nephrol Dial Transplant 2008; 23(4): 1135-43.
47. Rosenberger C, Khamaisi M, Abassi Z, et al. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int 2008; 73(1): 34-42.
48. Hirayama A, Nagase S, Ueda A, et al. In vivo imaging of oxidative stress in ischemia-reperfusion renal injury using electron paramagnetic resonance. Am J Physiol Renal Physiol 2005; 288(3): F597-603.
49. Subramanian S, Yamada K, Irie A, et al. Noninvasive in vivo oximetric imaging by radiofrequency FT EPR. Magn Reson Med 2002; 47(5): 1001-8.
50. Kempe S, Metz H, Mader K. Application of Electron Paramagnetic Resonance (EPR) spectroscopy and imaging in drug delivery research Chances and challenges. Eur J Pharm Biopharm 2010; 74(1): 55-6.
51. Matthews PM, Jezzard P. Functional magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2004; 75(1): 6-12.
52. Rajagopalan P, Krishnan KR, Passe TJ, Macfall JR. Magnetic resonance imaging using deoxyhemoglobin contrast versus positron emission tomography in the assessment of brain function. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19(3): 351-66.
53. Ugurbil K, Hu X, Chen W, et al. Functional mapping in the human brain using high magnetic fields. Philos Trans R Soc Lond B Biol Sci 1999; 354(1387): 1195-213.
54. Dunn JF, Swartz HM. Blood oxygenation. Heterogeneity of hypoxic tissues monitored using bold MR imaging. Adv Exp Med Biol 1997; 428: 645-50.
55. Prasad PV, Chen Q, Goldfarb JW, Epstein FH, Edelman RR. Breath-hold R2* mapping with a multiple gradient-recalled echo sequence: application to the evaluation of intrarenal oxygenation. J Magn Reson Imaging 1997; 7(6): 1163-5.
56. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996; 94(12): 3271-5.
57. Priatna A, Epstein FH, Spokes K, Prasad PV. Evaluation of changes in intrarenal oxygenation in rats using multiple gradientrecalled echo (mGRE) sequence. J Magn Reson Imaging 1999; 9(6): 842-6.
58. Epstein FH, Veves A, Prasad PV. Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care 2002; 25(3): 575-8.
59. Prasad PV, Epstein FH. Changes in renal medullary pO2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging: effects of aging and cyclooxygenase inhibition. Kidney Int 1999; 55(1): 294-8.
60. Tumkur SM, Vu AT, Li LP, Pierchala L, Prasad PV. Evaluation of intra-renal oxygenation during water diuresis: a time-resolved study using BOLD MRI. Kidney Int 2006; 70(1): 139-43.
61. Prasad PV, Priatna A, Spokes K, Epstein FH. Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J Magn Reson Imaging 2001; 13(5): 744-7.
62. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94(3): 1069-75.
63. Juillard L, Lerman LO, Kruger DG, et al. Blood oxygen leveldependent measurement of acute intra-renal ischemia. Kidney Int 2004; 65(3): 944-50.
64. Ries M, Basseau F, Tyndal B, et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen leveldependent. J Magn Reson Imaging 2003; 17(1): 104-13.
65. Li L, Storey P, Kim D, Li W, Prasad P. Kidneys in hypertensive rats show reduced response to nitric oxide synthase inhibition as evaluated by BOLD MRI. J Magn Reson Imaging 2003; 17(6): 671-5.
66. Li LP, Li BS, Storey P, et al. Effect of free radical scavenger (tempol) on intrarenal oxygenation in hypertensive rats as evaluated by BOLD MRI. J Magn Reson Imaging 2005; 21(3): 245-8.
67. Li LP, Ji L, Santos EA, et al. Effect of nitric oxide synthase inhibition on intrarenal oxygenation as evaluated by blood oxygenation level-dependent magnetic resonance imaging. Invest Radiol 2009; 44(2): 67-73.
68. Textor SC, Glockner JF, Lerman LO, et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 2008; 19(4): 780-8.
69. Cheung CM, Shurrab AE, Buckley DL, et al. MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease. Kidney Int 2006; 69(4): 715-22.
70. Breza J, Navratil P. Renal transplantation in adults. BJU Int 1999; 84(2): 216-23.
71. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63(7): 968-74.
72. Gainza FJ, Minguela I, Lopez-Vidaur I, Ruiz LM, Lampreabe I. Evaluation of complications due to percutaneous renal biopsy in allografts and native kidneys with color-coded Doppler sonography. Clin Nephrol 1995; 43(5): 303-8.
73. Preda A, Van Dijk LC, Van Oostaijen JA, Pattynama PM. Complication rate and diagnostic yield of 515 consecutive ultrasoundguided biopsies of renal allografts and native kidneys using a 14- gauge Biopty gun. Eur Radiol 2003; 13(3): 527-30.
74. Djamali A, Sadowski EA, Muehrer RJ, et al. BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. Am J Physiol Renal Physiol 2007; 292(2): F513-22.
75. Han F, Xiao W, Xu Y, et al. The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis. Nephrol Dial Transplant 2008; 23(8): 2666-72.
76. Malvezzi P, Bricault I, Terrier N, Bayle F. Evaluation of intrarenal oxygenation by blood oxygen level-dependent magnetic resonance imaging in living kidney donors and their recipients: preliminary results. Transplant Proc 2009; 41(2): 641-4.
77. Thoeny HC, Zumstein D, Simon-Zoula S, et al. Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology 2006; 241(3): 812-21.
78. Schachinger H, Klarhofer M, Linder L, Drewe J, Scheffler K. Angiotensin II decreases the renal MRI blood oxygenation leveldependent signal. Hypertension 2006; 47(6): 1062-6.
79. Bansal N, Szczepaniak L, Ternullo D, Fleckenstein JL, Malloy CR. Effect of exercise on (23)Na MRI and relaxation characteristics of the human calf muscle. J Magn Reson Imaging 2000; 11(5): 532-8.
80. Boada FE, Christensen JD, Huang-Hellinger FR, Reese TG, Thulborn KR. Quantitative in vivo tissue sodium concentration maps: the effects of biexponential relaxation. Magn Reson Med 1994; 32(2): 219-23.
81. Christensen JD, Barrere BJ, Boada FE, Vevea JM, Thulborn KR. Quantitative tissue sodium concentration mapping of normal rat brain. Magn Reson Med 1996; 36(1): 83-9.
82. Constantinides CD, Gillen JS, Boada FE, Pomper MG, Bottomley PA. Human skeletal muscle: sodium MR imaging and quantification-potential applications in exercise and disease. Radiology 2000; 216(2): 559-68.
83. Shapiro EM, Borthakur A, Gougoutas A, Reddy R. 23Na MRI accurately measures fixed charge density in articular cartilage. Magn Reson Med 2002; 47(2): 284-91.
84. Thulborn KR, Davis D, Adams H, Gindin T, Zhou J. Quantitative tissue sodium concentration mapping of the growth of focal cerebral tumors with sodium magnetic resonance imaging. Magn Reson Med 1999; 41(2): 351-9.
85. Bansal N, Seshan V. Three-dimensional triple quantum-filtered 23Na imaging of rabbit kidney with weighted signal averaging. J Magn Reson Imaging 1995; 5(6): 761-7.
86. Wolff SD, Eng C, Balaban RS. NMR studies of renal phosphate metabolites in vivo: effects of hydration and dehydration. Am J Physiol 1988; 255(4 Pt 2): F581-9.
87. Wolff SD, Eng J, Berkowitz BA, James S, Balaban RS. Sodium-23 nuclear magnetic resonance imaging of the rabbit kidney in vivo. Am J Physiol 1990; 258(4 Pt 2): F1125-31.
88. Maril N, Margalit R, Mispelter J, Degani H. Functional sodium magnetic resonance imaging of the intact rat kidney. Kidney Int 2004; 65(3): 927-35.
89. Maril N, Margalit R, Mispelter J, Degani H. Sodium magnetic resonance imaging of diuresis: spatial and kinetic response. Magn Reson Med 2005; 53(3): 545-52.
90. Maril N, Margalit R, Rosen S, Heyman SN, Degani H. Detection of evolving acute tubular necrosis with renal 23Na MRI: studies in rats. Kidney Int 2006; 69(4): 765-8.
91. Jamison RL, Oliver RE. Disorders of urinary concentration and dilution. Am J Med 1982; 72(2): 308-22.
92. Lote C. Principles of renal physiology. London: Chapman & Hall; 1994.
93. Boulanger Y, Vinay P. Nuclear magnetic resonance monitoring of sodium in biological tissues. Can J Physiol Pharmacol 1989; 67(8): 820-828.
94. Maril N, Rosen Y, Reynolds GH, et al. Sodium MRI of the human kidney at 3 Tesla. Magn Reson Med 2006; 56(6): 1229-34.
95. Rosen Y, Lenkinski RE. Sodium MRI of a human transplanted kidney. Acad Radiol 2009; 16(7): 886-89.
96. Lassen NA, Perl W. Tracer kinetic methods in medical physiology. New York: Raven; 1979.
97. Zierler KL. Equations for Measuring Blood Flow by External Monitoring of Radioisotopes. Circ Res 1965; 16: 309-21.
98. Davis CP, McKinnon GC, Debatin JF, von Schulthess GK. Ultrahigh-speed MR imaging. Eur Radiol 1996; 6(3): 297-311.
99. Nitz WR. Fast and ultrafast non-echo-planar MR imaging techniques. Eur Radiol 2002; 12(12): 2866-82.
100. Perman WH, Gado MH, Larson KB, Perlmutter JS. Simultaneous MR acquisition of arterial and brain signal-time curves. Magn Reson Med 1992; 28(1): 74-83.
101. Lassen NA. Cerebral transit of an intravascular tracer may allow measurement of regional blood volume but not regional blood flow. J Cereb Blood Flow Metab 1984; 4(4): 633-4.
102. Stewart GN. Researches on the Circulation Time in Organs and on the Influences which affect it: Parts I.-III. J Physiol 1893; 15(1-2): 1-89.
103. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993; 29(4): 553-8.
104. Morell A, Ahlstrom H, Schoenberg SO, et al. Quantitative renal cortical perfusion in human subjects with magnetic resonance imaging using iron-oxide nanoparticles: influence of T1 shortening. Acta Radiol 2008; 49(8): 955-62.
105. Giebisch G, Windhager E. Glomerular filtration and renal blood flow. In: Boron WF, Boulpaep EL, editors. Medical physiology: a cellular and molecular approach. Philadelphia: Saunders 2003; 757-73.
106. Greger R. Introduction to renal function, renal blood flow and the formation of filtrate. Comprehensive human physiology: from cellular mechanisms to integration. Berlin: Springer 1996; 1469-87.
107. Mostafavi MR, Chavez DR, Cannillo J, Saltzman B, Prasad PV. Redistribution of renal blood flow after SWL evaluated by GdDTPA-enhanced magnetic resonance imaging. J Endourol 1998; 12(1): 9-12.
108. Michaely HJ, Schoenberg SO, Oesingmann N, et al. Renal artery stenosis: functional assessment with dynamic MR perfusion measurements--feasibility study. Radiology 2006; 238(2): 586-96.
109. Choyke PL, Austin HA, Frank JA, et al. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Kidney Int 1992; 41(6): 1595-8.
110. Coulam CH, Lee JH, Wedding KL, et al. Noninvasive measurement of extraction fraction and single-kidney glomerular filtration rate with MR imaging in swine with surgically created renal arterial stenoses. Radiology 2002; 223(1): 76-82.
111. Dumoulin CL, Buonocore MH, Opsahl LR, et al. Noninvasive measurement of renal hemodynamic functions using gadolinium enhanced magnetic resonance imaging. Magn Reson Med 1994; 32(3): 370-378.
112. Niendorf ER, Grist TM, Lee FT, Jr., Brazy PC, Santyr GE. Rapid in vivo measurement of single-kidney extraction fraction and glomerular filtration rate with MR imaging. Radiology 1998; 206(3): 791-8.
113. Katzberg RW, Buonocore MH, Low R, et al. MR determination of glomerular filtration rate in subjects with solitary kidneys in comparison to clinical standards of renal function: feasibility and preliminary report. Contrast Media Mol Imaging 2009; 4(2): 51-65.
114. Baumann D, Rudin M. Quantitative assessment of rat kidney function by measuring the clearance of the contrast agent Gd(DOTA) using dynamic MRI. Magn Reson Imaging 2000; 18(5): 587-95.
115. Laurent D, Poirier K, Wasvary J, Rudin M. Effect of essential hypertension on kidney function as measured in rat by dynamic MRI. Magn Reson Med 2002; 47(1): 127-34.
116. Smith AM, Materne R, Van Beers BE. Quantitative measurement of blood perfusion, GFR and arterial vascular fraction in the kidney cortex.; 2001; Honolulu. International Society of Magnetic Resonance in Medicine. 367.
117. Lee VS, Rusinek H, Bokacheva L, et al. Renal function measurements from MR renography and a simplified multicompartmental model. Am J Physiol Renal Physiol 2007; 292(5): F1548-59.
118. Hackstein N, Heckrodt J, Rau WS. Measurement of single-kidney glomerular filtration rate using a contrast-enhanced dynamic gradient-echo sequence and the Rutland-Patlak plot technique. J Magn Reson Imaging 2003; 18(6): 714-25.
119. Hackstein N, Kooijman H, Tomaselli S, Rau WS. Glomerular filtration rate measured using the Patlak plot technique and contrast-enhanced dynamic MRI with different amounts of gadolinium-DTPA. J Magn Reson Imaging 2005; 22(3): 406-14.
120. Kirsch AJ, McMann LP, Jones RA, et al. Magnetic resonance urography for evaluating outcomes after pediatric pyeloplasty. J Urol 2006; 176(4 Pt 2): 1755-61.
121. Bokacheva L, Rusinek H, Zhang JL, Chen Q, Lee VS. Estimates of glomerular filtration rate from MR renography and tracer kinetic models. J Magn Reson Imaging 2009; 29(2): 371-82.
122. Annet L, Hermoye L, Peeters F, et al. Glomerular filtration rate: assessment with dynamic contrast-enhanced MRI and a corticalcompartment model in the rabbit kidney. J Magn Reson Imaging 2004; 20(5): 843-9.
123. Buckley DL, Shurrab AE, Cheung CM, et al. Measurement of single kidney function using dynamic contrast-enhanced MRI: comparison of two models in human subjects. J Magn Reson Imaging 2006; 24(5): 1117-23.
124. Zhang JL, Rusinek H, Bokacheva L, et al. Functional assessment of the kidney from magnetic resonance and computed tomography renography: impulse retention approach to a multicompartment model. Magn Reson Med 2008; 59(2): 278-288.
125. Agarwal R, Brunelli SM, Williams K, et al. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. Nephrol Dial Transplant 2009; 24(3): 856-863.
126. Chrysochou C, Buckley DL, Dark P, Cowie A, Kalra PA. Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience. J Magn Reson Imaging 2009; 29(4): 887-94.
127. Kuo PH. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF. J Am Coll Radiol 2008; 5(1): 29-35.
128. Lewis J, Wolf G, Prasad PV, et al. MRI Based Renal Imaging with Ferumoxytol: Perfusion-Enhanced MRI in a Rabbit Model. Renal Week; 2009; Oct. 27 Nov. 1; San Diego, CA. American Society of Nephrology. p SA-PO2979. (Renal Week).
129. MacFall JR, Charles HC, Black RD, et al. Human lung air spaces: potential for MR imaging with hyperpolarized He-3. Radiology 1996; 200(2): 553-558.
130. rd, et al. Hyperpolarized noble gas MR imaging of the lung: potential clinical applications. Eur J Radiol 2001; 40(1): 33-44.
131. Salerno M, de Lange EE, Altes TA, et al. Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes--initial experience. Radiology 2002; 222(1): 252-60.
132. Golman K, Axelsson O, Johannesson H, et al. Parahydrogeninduced polarization in imaging: subsecond (13)C angiography. Magn Reson Med 2001; 46(1): 1-5.
133. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc Natl Acad Sci U S A 2003; 100(18): 10435-10439.
134. Svensson J, Mansson S, Johansson E, Petersson JS, Olsson LE. Hyperpolarized 13C MR angiography using trueFISP. Magn Reson Med 2003; 50(2): 256-62.
135. Johansson E, Mansson S, Wirestam R, et al. Cerebral perfusion assessment by bolus tracking using hyperpolarized 13C. Magn Reson Med 2004; 51(3): 464-72.
136. Mori S, Eleff SM, Pilatus U, Mori N, van Zijl PC. Proton NMR spectroscopy of solvent-saturable resonances: a new approach to study pH effects in situ. Magn Reson Med 1998; 40(1): 36-42.
137. Stubbs M, Bhujwalla ZM, Tozer GM, et al. An assessment of 31P MRS as a method of measuring pH in rat tumours. NMR Biomed 1992; 5(6): 351-9.
138. van Sluis R, Bhujwalla ZM, Raghunand N, et al. In vivo imaging of extracellular pH using 1H MRSI. Magn Reson Med 1999; 41(4): 743-50.
139. Raghunand N, Howison C, Sherry AD, Zhang S, Gillies RJ. Renal and systemic pH imaging by contrast-enhanced MRI. Magn Reson Med 2003; 49(2): 249-57.
140. Michaely HJ, Schoenberg SO, Ittrich C, et al. Renal disease: value of functional magnetic resonance imaging with flow and perfusion measurements. Invest Radiol 2004; 39(11): 698-705.